The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels

Cell Calcium

Volumn 45, Issue 5, 2009, Pages 431-438

  Karlsson, Jennie ^a   Stenfeldt, Anna Lena ^a   Rabiet, Marie Josèphe ^b,c,d   Bylund, Johan ^a   Forsman, Huamei Fu ^a   Dahlgren, Claes ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CEA GRENOBLE   (France)

^c CNRS   (France)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

Antagonists; Calcium influx; Calcium signaling physiology; Extracellular intracellular calcium; Formyl peptide receptors; G protein coupled receptors GPCR; Granulocyte; Human; Inhibitors pharmacology; Ligands; NADPH oxidase blood; Neutrophil; Priming; Receptor; Store operated calcium channels

Indexed keywords

CALCIUM CHANNEL; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; FORMYLPEPTIDE RECEPTOR LIKE 2; MMK 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 65549106787     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2009.02.002     Document Type: Article

References (53)

1. Partida-Sanchez S., Iribarren P., Moreno-Garcia M.E., et al. Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose. J. Immunol. 172 (2004) 1896-1906
2. Laudanna C., and Alon R. Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes. Thromb. Haemost. 95 (2006) 5-11
3. Uhing R.J., and Snyderman R. Chemoattractant stimulus-response coupling. In: Gallin J.I., and Snyderman R. (Eds). Inflammation: Basic Principles and Clinical Correlates (1999), Lippincott, Williams & Wilkins, Philadelphia, PA 607-626
4. Cassimeris L., and Zigmond S.H. Chemoattractant stimulation of polymorphonuclear leucocyte locomotion. Semin. Cell Biol. 1 (1990) 125-134
5. Baggiolini M., Boulay F., Badwey J.A., and Curnutte J.T. Activation of neutrophil leukocytes: chemoattractant receptors and respiratory burst. FASEB J. 7 (1993) 1004-1010
6. Bagorda A., Mihaylov V.A., and Parent C.A. Chemotaxis: moving forward and holding on to the past. Thromb. Haemost. 95 (2006) 12-21
7. Boulay F., Naik N., Giannini E., Tardif M., and Brouchon L. Phagocyte chemoattractant receptors. Ann. N. Y. Acad. Sci. 832 (1997) 69-84
8. Rabiet M.J., Huet E., and Boulay F. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 89 (2007) 1089-1106
9. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12 (1994) 593-633
10. Miller A.F., and Falke J.J. Chemotaxis receptors and signaling. Adv. Protein Chem. 68 (2004) 393-444
11. M. Baggiolini, Introduction to chemokines and chemokine antagonists, Ernst Schering Res Found Workshop, 2004, pp. 1-9.
12. Heit B., Tavener S., Raharjo E., and Kubes P. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159 (2002) 91-102
13. Ye R.D., and Boulay F. Structure and function of leukocyte chemoattractant receptors. Adv. Pharmacol. 39 (1997) 221-289
14. Le Y., Murphy P.M., and Wang J.M. Formyl-peptide receptors revisited. Trends Immunol. 23 (2002) 541-548
15. Fu H., Karlsson J., Bylund J., Movitz C., Karlsson A., and Dahlgren C. Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79 (2006) 247-256
16. Rabiet M.J., Huet E., and Boulay F. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur. J. Immunol. 35 (2005) 2486-2495
17. Bellner L., Thoren F., Nygren E., Liljeqvist J.A., Karlsson A., and Eriksson K. A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions. J. Immunol. 174 (2005) 2235-2241
18. Bylund J., Christophe T., Boulay F., Nystrom T., Karlsson A., and Dahlgren C. Proinflammatory activity of a cecropin-like antibacterial peptide from Helicobacter pylori. Antimicrob. Agents Chemother. 45 (2001) 1700-1704
19. Su S.B., Gong W., Gao J.L., et al. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189 (1999) 395-402
20. Le Y., Yazawa H., Gong W., et al. The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J. Immunol. 166 (2001) 1448-1451
21. Christophe T., Karlsson A., Dugave C., Rabiet M.J., Boulay F., and Dahlgren C. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276 (2001) 21585-21593
22. Hu J.Y., Le Y., Gong W., et al. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leukoc. Biol. 70 (2001) 155-161
23. Dahlgren C., Christophe T., Boulay F., Madianos P.N., Rabiet M.J., and Karlsson A. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 95 (2000) 1810-1818
24. Thelen M., and Wirthmueller U. Phospholipases and protein kinases during phagocyte activation. Curr. Opin. Immunol. 6 (1994) 106-112
25. Bokoch G.M. Chemoattractant signaling and leukocyte activation. Blood 86 (1995) 1649-1660
26. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 361 (1993) 315-325
27. 2+ influx: what is the message from the stores to the membrane?. J. Lab. Clin. Med. 128 (1996) 19-26
28. Putney Jr. J.W. A model for receptor-regulated calcium entry. Cell Calcium 7 (1986) 1-12
29. 2+ entry. J. Cell Sci. 120 (2007) 1959-1965
30. Betten A., Dahlgren C., Hermodsson S., and Hellstrand K. Histamine inhibits neutrophil NADPH oxidase activity triggered by the lipoxin A4 receptor-specific peptide agonist Trp-Lys-Tyr-Met-Val-Met. Scand. J. Immunol. 58 (2003) 321-326
31. Bylund J., Karlsson A., Boulay F., and Dahlgren C. Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1. Infect. Immun. 70 (2002) 2908-2914
32. Fu H., Bylund J., Karlsson A., Pellme S., and Dahlgren C. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8. Immunology 112 (2004) 201-210
33. Fiore S., and Serhan C.N. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochemistry 34 (1995) 16678-16686
34. Parkinson J.F. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation. Inflamm. Allergy Drug Targets 5 (2006) 91-106
35. Christophe T., Karlsson A., Rabiet M.J., Boulay F., and Dahlgren C. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. Scand. J. Immunol. 56 (2002) 470-476
36. Fu H., Bjorkman L., Janmey P., et al. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide. BMC Cell Biol. 5 (2004) 50
37. Cunningham C.C., Vegners R., Bucki R., et al. Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly. J. Biol. Chem. 276 (2001) 43390-43399
38. Tardif M., Rabiet M.J., Christophe T., Milcent M.D., and Boulay F. Isolation and characterization of a variant HL60 cell line defective in the activation of the NADPH oxidase by phorbol myristate acetate. J. Immunol. 161 (1998) 6885-6895
39. Tonetti D.A., Henning-Chubb C., Yamanishi D.T., and Huberman E. Protein kinase C-beta is required for macrophage differentiation of human HL-60 leukemia cells. J. Biol. Chem. 269 (1994) 23230-23235
40. Lundqvist H., and Dahlgren C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic. Biol. Med. 20 (1996) 785-792
41. Dahlgren C., and Karlsson A. Respiratory burst in human neutrophils. J. Immunol. Methods 232 (1999) 3-14
42. Sarndahl E., Lindroth M., Bengtsson T., et al. Association of ligand-receptor complexes with actin filaments in human neutrophils: a possible regulatory role for a G-protein. J. Cell Biol. 109 (1989) 2791-2799
43. Jesaitis A.J., Tolley J.O., and Allen R.A. Receptor-cytoskeleton interactions and membrane traffic may regulate chemoattractant-induced superoxide production in human granulocytes. J. Biol. Chem. 261 (1986) 13662-13669
44. Karlsson J., Fu H., Boulay F., Bylund J., and Dahlgren C. The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists. Biochem. Pharmacol. 71 (2006) 1488-1496
45. Bjorkman L., Karlsson J., Karlsson A., et al. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. J. Leukoc. Biol. 83 (2008) 245-253
46. 2+ influx across the plasma membrane of human neutrophils. Mol. Pharmacol. 30 (1986) 437-443
47. Gavins F.N., Yona S., Kamal A.M., Flower R.J., and Perretti M. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 101 (2003) 4140-4147
48. Bae Y.S., Lee H.Y., Jo E.J., et al. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173 (2004) 607-614
49. Wenzel-Seifert K., and Seifert R. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-l-phenylalanyl-l-leucyl-l-phenylalanyl-l-leucyl-l-phenylalanine and cyclosporins A, B, C, D, and E. J. Immunol. 150 (1993) 4591-4599
50. Clapham D.E. Calcium signaling. Cell 80 (1995) 259-268
51. Bootman M.D., and Berridge M.J. The elemental principles of calcium signaling. Cell 83 (1995) 675-678
52. Le Y., Gong W., Tiffany H.L., et al. Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21 (2001) RC123
53. Le Y., Ye R.D., Gong W., Li J., Iribarren P., and Wang J.M. Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS J. 272 (2005) 769-778